Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the recipient of a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 4,105 shares, a decline of 38.1% from the May 31st total of 6,628 shares. Based on an average daily trading volume, of 1,397 shares, the short-interest ratio is presently 2.9 days.
Biofrontera Price Performance
Shares of Biofrontera stock remained flat at $0.03 during trading hours on Friday. 704 shares of the stock were exchanged, compared to its average volume of 6,009. The business’s fifty day moving average is $0.03 and its 200 day moving average is $0.05. Biofrontera has a one year low of $0.02 and a one year high of $0.28.
About Biofrontera
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Featured Articles
- Five stocks we like better than Biofrontera
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
- Why the Comcast Spin-Off Won’t Fix What’s Actually Broken
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
